iShares Nasdaq Biotechnology ETF Stock Forecast, Price & News

iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Frequently Asked Questions

How has iShares Nasdaq Biotechnology ETF's stock price been impacted by Coronavirus (COVID-19)?

iShares Nasdaq Biotechnology ETF's stock was trading at $106.97 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IBB shares have increased by 23.2% and is now trading at $131.83.
View which stocks have been most impacted by COVID-19.

How often does iShares Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for iShares Nasdaq Biotechnology ETF?

iShares Nasdaq Biotechnology ETF announced a quarterly dividend on Friday, December 10th. Investors of record on Tuesday, December 14th will be paid a dividend of $0.041 per share on Friday, December 17th. This represents a $0.16 dividend on an annualized basis and a yield of 0.12%. The ex-dividend date is Monday, December 13th.
View iShares Nasdaq Biotechnology ETF's dividend history.

Is iShares Nasdaq Biotechnology ETF a good dividend stock?

iShares Nasdaq Biotechnology ETF pays an annual dividend of $0.32 per share and currently has a dividend yield of 0.24%.
View iShares Nasdaq Biotechnology ETF's dividend history.

When did iShares Nasdaq Biotechnology ETF's stock split? How did iShares Nasdaq Biotechnology ETF's stock split work?

iShares Nasdaq Biotechnology ETF shares split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were distributed to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

Who are iShares Nasdaq Biotechnology ETF's key executives?

iShares Nasdaq Biotechnology ETF's management team includes the following people:

• George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees
• Michael Arthur Latham, President, Trustee
• Jack Gee, Chief Financial Officer, Treasurer
• Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
• , Bio & Compensation - 
• Amy Schioldager, Executive Vice President
• Ira P. Shapiro, Vice President, Chief Legal Officer
• Matt Tucker, Vice President
• , Bio & Compensation - 
• Eilleen M. Clavere, Secretary
• Cecilia H. Herbert, Independent Trustee
• Charles A. Hurty, Independent Trustee

Who are some of iShares Nasdaq Biotechnology ETF's key competitors?

Some companies that are related to iShares Nasdaq Biotechnology ETF include SPDR Dow Jones Industrial Average ETF Trust (DIA), iShares MSCI Emerging Markets ETF (EEM), Consumer Discretionary Select Sector SPDR Fund (XLY), SPDR Bloomberg Barclays High Yield Bond ETF (JNK), SPDR Nuveen Barclays Short Term Municipal Bond ETF (SHM), SPDR Nuveen Barclays Municipal Bond ETF (TFI), DNP Select Income Fund (DNP), Direxion Daily Financial Bull 3X Shares (FAS), iShares MSCI Pacific ex Japan ETF (EPP), Adams Diversified Equity Fund (ADX), Nuveen Municipal Value Fund (NUV), Goldman Sachs BDC (GSBD), Hercules Capital (HTGC), WisdomTree Emerging Markets High Dividend Fund (DEM) and The Gabelli Equity Trust (GAB).
View all of IBB's competitors.

What other stocks do shareholders of iShares Nasdaq Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).

What is iShares Nasdaq Biotechnology ETF's stock symbol?

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

Who are iShares Nasdaq Biotechnology ETF's major shareholders?

iShares Nasdaq Biotechnology ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Cutler Group LP (0.00%), Rye Brook Capital LLC (0.14%), Alpha Cubed Investments LLC (0.14%), McGuire Investment Group LLC (0.09%), DeDora Capital Inc. (0.08%) and Avondale Wealth Management (0.08%).

Which institutional investors are selling iShares Nasdaq Biotechnology ETF stock?

IBB stock was sold by a variety of institutional investors in the last quarter, including Stratos Wealth Advisors LLC, McGuire Investment Group LLC, CAPROCK Group Inc., Stratos Wealth Partners LTD., Brookstone Capital Management, Bank of New Hampshire, Avondale Wealth Management, and Neville Rodie & Shaw Inc..

Which institutional investors are buying iShares Nasdaq Biotechnology ETF stock?

IBB stock was purchased by a variety of institutional investors in the last quarter, including Cutler Group LP, DeDora Capital Inc., Rye Brook Capital LLC, Alpha Cubed Investments LLC, Blue Fin Capital Inc., Crescent Capital Consulting LLC, Arlington Financial Advisors LLC, and Coastal Investment Advisors Inc..

How do I buy shares of iShares Nasdaq Biotechnology ETF?

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Nasdaq Biotechnology ETF's stock price today?

One share of IBB stock can currently be purchased for approximately $131.83.

How much money does iShares Nasdaq Biotechnology ETF make?

iShares Nasdaq Biotechnology ETF has a market capitalization of $8.74 billion.